If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Find us on

Une PME sur quatre, dans le rouge !

Près d’un quart des PME suisses membres de Swissmen, ont bouclé l’année 2016 en déficit....

Naissance d’un fonds de capital-risque géant de 300 Mio au coeur de la Health Valley

Depuis quelques années les start-up suisses, et plus généralement européennes, ont moins de mal à...

Rupture de croissance pour la biotech

Présenté en exclusivité lors de la soirée exclusive EY/ Inartis « Beyond Borders » dans le cadre...

Saga Clozel – Un duo qui crève les plafonds boursiers

Jean-Paul et Martine Clozel. Une histoire d’amour et de prospérité persistante. Après la réussite d’une...

Spéculation : faut-il acheter des actions pharma ?

La pharma vient de subir une forte correction sur le marché boursier. Est-ce le moment...

MassChallenge Switzerland débute sa 2ème édition à UniverCité/Renens

Les crayons des 72 startups de la promotion 2017 de MassChallenge Switzerland sont parfaitement taillés...

Johann Schneider-Ammann parie sur un franc fort à l’automne

Invité d’honneur du Salon EPHJ-EPMT-SMT, ambassadeur de la Health Valley, Johann Schneider-Ammann s’est annoncé confiant...

Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor

Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment...

Le système de santé Suisse est-il à la hauteur de sa réputation ?

La Suisse arrive au deuxième rang de l’Indice européen des consommateurs de soins de santé...

Cellules souches : La Suisse va évaluer le Cx601 de TiGenix

Suspension de cellules souches allogéniques expansées dérivées de tissus adipeux (eASC) administrée localement pour le...

Biopôle announces StartLab, tailor-made Incubator for Life Sciences Entrepreneurs

Biopôle SA, a leading Swiss life sciences park, today announced the creation of StartLab, the first incubator dedicated to life sciences located in the Canton of Vaud.

Apidel SA announces R&D collaboration with DNDi in the field of neglected diseases

Apidel announces the signature of an agreement to collaborate with DNDi on the preclinical development of a topical treatment for Cutaneous Leishmaniasis, a neglected disease affecting between 0.7 to 1.2 million people worldwide. A promising drug candidate will be tested with Apidel’s proprietary drug delivery technology ApidSOL™.

Merck KGaA, Darmstadt, Germany Licenses Selexis SUREtechnology Platform for Immuno-Oncology Antibody

Geneva, Switzerland, 30 MAY 2017 – Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today that it has entered an agreement with an affiliate of Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, to leverage the Selexis SUREtechnology Platform™ and SURE CHO-M (suspension-adapted CHO-K1) cell line to advance a Merck KGaA, Darmstadt, Germany immuno-oncology antibody program.

Selexis SA and OSE Immunotherapeutics Sign Commercial License Agreement to Further Advance Developme

Selexis SA and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today the signing of a commercial license agreement that provides OSE Immunotherapeutics with access to high performance research cell banks (RCBs) from the Selexis SUREtechnology Platform™. The agreement builds upon previous collaboration between the two companies as announced in November 2016 and is designed to support the advancement of the clinical development of OSE’s interleukin receptor 7 antagonist, OSE-127 (Effi-7), under development as a potential treatment for inflammatory bowel diseases, such as ulcerative colitis.
Archive:  2017  2016  2015  2014  2013  2012  2011  2010 
Find an actor

4à6 de BioAlps - Straumann15.06.2017

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

Biopôle announces StartLab, tailor-made Incubator for Life Sciences Entrepreneurs

Biopôle SA, a leading Swiss life sciences park, today announced the creation of StartLab, the first incubator...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

E-mail address